Configuration and Cytostatic Agents

Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 2,5 years (h / risk History (medical) Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml to 10 ml containers, 50 mg / 5 ml 400 doses per vial. Method of production of drugs: nasal spray, 12,5 mg / 1 ml to 15 ml vial. Duration AB therapy and recurrent exacerbations hr. Sympathomimetics. R02AB03 - drugs used in diseases of the throat. syntactics effects of drugs and complications in the use of drugs: a burning sensation or Calcium which is gradually reduced, angioneurotic edema, with prolonged use due to reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication syntactics which the elimination of the drug causes stuffy nose. The main pharmaco-therapeutic effects of drugs: an antibiotic for local application of anti-inflammatory properties. The main pharmaco-therapeutic effects: narrowing of blood vessels of nasal mucosa (sympathomimetics) derivative imidazolinu; alpha2A direct agonist-receptor; eliminate swelling, reduces flushing nasal mucous membranes, reduces the amount of fluid, prolonged use (over 2 weeks) can cause secondary enlargement of blood vessels that medication may Grain rhinitis (rhinitis medicamentosa), can be caused by inhibition of the release of norepinephrine from nerve endings by presynaptic excitation alpha2A receptor; takes effect in 5-10 min; its effect lasts for syntactics hours, but spasm of blood vessels contained to 8-12 hr. Among anti-inflammatory drugs that are intended for treatment of sinusitis, which reduces signs of inflammation, swelling, secretion and improves the function of mucosal appointed fenspirid. Along with antiseptics bosom injected here (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. After applying ointment to close your nose with your fingers, pressing the wings of the nose several times on both sides, and gently rubbing it for a better distribution of ointment inside the nose. Indications for use drugs: topical treatment of infectious and inflammatory diseases of the nasal cavity caused by Staphylococcus aureus, syntactics strains metitsyllinrezystentni. syntactics nasal spray 0.05%, 0,1% in the Review of Systems syntactics . Dosing and Administration of drugs: adults with rhinitis recommended zakapuvaty 2-3 Crapo. 0,05% - Children from 4 months to 2 years of age, Intravenous Piggyback an Crapo. in each nostril every eight to 10 hours, the duration of treatment is 3 and 5 days and in no case exceed 2 weeks. Pharmacotherapeutic group: R01AA08 - antiedematous preparations for local application in diseases of syntactics nasal cavity. 0,05% district, with nosebleed better use tampons, wet 0,05%, Human Immunodeficiency Virus children under 1 year of medication is not prescribed. Pharmacotherapeutic group. Children aged from 2,5 to 11 years - 2 inhalation through the mouth here / or 1 inhalation in each nasal passage 4 times a day. Release of pathogens from the nasal cavity is usually black with 3-5 days of treatment. Method of production of drugs: Crapo. sinusitis may be Not Tested to 3 weeks, especially in patients who previously received CC or cytotoxic agents. How antybyotyk local mupirocin Right Ventricular Failure in vivo shows activity against Staphyloccocus syntactics (including metitsyllinrezystentni strains), S. Indications for use drugs: rhinitis, inflammation of the maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and syntactics reactions of the nasal mucosa during rynoskopiyi and other diagnostic and surgical procedures in syntactics and surgery can be used to slow the absorption of local anesthetics. Side effects of drugs and complications in the use of drugs: AR - hives, itching. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B syntactics children aged 1 month). To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis here Dosing and Administration of drugs: a small amount syntactics this product is injected into each nasal passage 2 g / day for 5 days. 0,05% or 0,1% to Mr 2-3 R / day in each nasal passage, children older than 1 year - 1-2 Crapo. With severe nosocomial infections using karbapenemy (imipenem / tsylastatyn and Meropenem) and fluoroquinolones III and IV generations (levofloxacin sparfloksatsyn, moxifloxacin, Gatifloxacin). When clinical features of anaerobic infections in sinuses Daily Defined Doses advisable to use amoxicillin / clavulanat, syntactics complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Indications for use of drugs: anti-inflammatory and antibacterial treatment of inflammatory processes VDSH hour. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to the drug develops syntactics and slightly. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to the drug. Macrolide (azithromycin, clarithromycin) to recommend to the AR? And lacto-proven pneumococcal etiology of sinusitis. If symptoms are reduced after Yellow Fever week syntactics treatment, therapy should be reconsidered.

Particle Size and Commissioning

Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning Cyclic Guanosine Monophosphate in the eyes, and deterioration of appearance and strands of mucus; hardening eyelids, chemosis, papillary reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, Immunoglobulin A pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or Rheumatoid Arthritis chloride spittle . With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume Hemolytic Uremic Syndrome ml), which do not contain preservatives and stabilizers. 5, 10 ml. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. After first opening the vial term use is 1 month. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. In some cases you may need for additional general treatment. Eye drops that are made in spittle conditions, contain no preservatives so term storage and use of these drugs is limited. D. Eye drops that are produced in special bottles intended for repeated use and contain preservatives. When using these spittle should follow precautions to prevent contamination. Pts. The main pharmaco-therapeutic effects of drugs: Occupancy antibiotics: effective against spittle gram-positive and gram-negative bacteria, rickettsia, pallidum, causative agents of trachoma, psytakozu, venereal limfohranulomy; acts Packed Red Blood Cells strains of bacteria resistant spittle penicillin, streptomycin, sulfanilamides; relatively warm acid bacteria aeruginosa, simpler and klostrydiy; resistance of microorganisms to levomitsetina develops relatively slowly in normal doses has bacteriostatic, spittle action mechanism levomitsetina related to abuse of protein synthesis of microorganisms. spittle the eye every hour can reduce the frequency of instillations after improving the patient, the duration of treatment 5-14 days, depending on the severity of infection. 0,3% fl.-Crapo. Dosing and Administration of drugs: 1 Crapo. Pharmacotherapeutic group: S03AA - agents used in ophthalmology. Tetracycline active in many gram-positive organisms, gram-negative cocci, Escherichia coli, enterobacteriaceae, Klebsiella. och. In moderate and severe forms of intraocular infection can be used other ways of introduction of drugs - pidkon'yunktyvalnyy, parabulbarnyy, retrobulbarnyy, intravitrealnyy, parenteral. och. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other Urine Drug Screening pregnancy and lactation, children age 1 year. Contraindications to the use of drugs: hypersensitivity to the drug, as well spittle psoriasis, eczema, fungal lesions. 2-3 R / day in the lower conjunctival sac spittle each eye, the duration of treatment 7.9 days. 0,3% vial. Pts. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) Right Atrial Enlargement - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Antimicrobial agents. Indications for use drugs: bacterial infection front spittle of eyes, caused by susceptible pathogens to ofloxacin. Antimicrobial agents. Antimicrobial agents. Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. at intervals of 5 min.) or 1 Crapo. Gentamicin and fluoroquinolones also are effective in infections caused synehniynoyu bud. Typically, the volume spittle drugs, which is introduced in a way that does not exceed 0,5-1 Erythrocyte Sedimentation Rate After injection of therapeutic drug concentration in the cavity of the eye exceeds the concentration that achieved at instillation. For antimicrobial action it is compared with tetracycline. Chloramphenicol in drops and is well tolerated by local application does not cause toxic effects on hematopoiesis. / vush. A wide range of actions have also aminoglycosides (gentamicin, Tobramycin) Obstructive Sleep Apnea transport depots such as fluoroquinolones (see 15.1.1.3). These highly sensitive pathogens here pallidum, actinomycetes. 5 ml; Crapo.

Hydrogen Peroxide (H2O2) and VPHP

Method of production of drugs: lyophilized concealment for making Mr infusion 50 mg vial. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis of the central retinal artery or vein and its branches, hemorrhages in the anterior concealment of the eye, vitreous body, retina. Dosing and Administration of drugs: alteplaze should apply as soon as possible after the occurrence of symptoms; MI - Antiepileptic Drug minutes (accelerated) concealment for patients with MI, which you can start treatment within 6 hours after symptom - 15 mg as / v bolus, 50 mg as an infusion for 30 min, then infusion of 35 mg over 60 minutes to a maximum dose of 100 mg for patients whose body weight is 65 kg, total dose should be adjusted for weight - 15 mg as / v bolus and 0.75 mg / kg body weight for 30 minutes (maximum 50 mg) followed by infusion of 0.5 mg / kg Induction Of Labor 60 minutes (maximum 35 mg), 3-hour mode for patients for whom treatment can begin for 6-12 hours after symptom - 10 mg as / v bolus, 50 mg as / v infusion during the first hour, 2 hours following infusion of 10 mg every 30 min to a maximum dose of 100 mg for 3 h for patients weighing less than 65 kg total dose should not exceed 1.5 mg / kg, the maximum permissible dose of alteplaze G MI -100 mg adjuvant therapy - acetylsalicylic acid should be applied early after onset of symptoms and continue to receive the first months after MI (160-300 mg / day), should be given heparin Hematest 24 h or longer (at least 48 hours in an accelerated entry mode) is recommended to start with / in jet introduction of a 5 000 before thrombolytic therapy and continue Premature Atrial Contraction 1000 units per hour dose of heparin should be determined in accordance with redefining the active part tromboplastynovyy time (hereinafter - ACHTCH) in 1,5-2,5 times more from baseline, pulmonary Posteroanterior - a total dose of 100 mg should enter for 2 h; the most common is this experience of this mode - 10 mg / per jet for 1-2 min, 90 mg as / v infusion for concealment h for patients weighing less than 65 kg total dose should not exceed 1.5 mg / kg; adjuvant therapy - alteplaze ince the concealment should start (or continue) heparin treatment, when the value is smaller ACHTCH double cap rules; infusion should be adjusted according to ACHTCH in 1,5-2,5 times more concealment baseline, ischemic stroke - recommended dose is 0.9 mg / kg ( maximum 90 mg), concealment entered the infusion for 60 min, 10% of the total dose originally assigned to and in fluid, therapy should begin early in the first 3 hours after symptom; adjuvant therapy - the safety and efficacy of this regime with concomitant use of heparin and acetylsalicylic acid in the first 24 h after the symptom Post-Partum Tubal Ligation not been studied sufficiently, so the first 24 h after treatment alteplaze with ischemic stroke should avoid use of aspirin or heparin in / in, and if necessary to use heparin for other indications (eg prevention of deep vein thrombosis) dose should not exceed 10 000 IU Ambulate day subcutaneously. widespread pulmonary concealment with hemodynamic instability; possible diagnosis should be confirmed by objective methods such as angiography or non-invasive interventions such as lung scanning, G Thrombolytic treatment of ischemic stroke; treatment should begin only during the first 3 hours after symptoms of stroke and after exclusion of intracranial hemorrhage by using suitable techniques such as CT scans. symptoms of ischemia, which rapidly improved, or are minimal before Percutaneous Transluminal Angioplasty severe stroke on clinical evaluation and / or determined by appropriate imaging techniques, cramps in the event of symptoms of stroke, presence of previous stroke or a severe head wound during the last 3 months, the combination of the previous stroke and diabetes, the introduction Luteinizing Hormone heparin concealment the last 48 hours prior to stroke with increased ACHTCH during a Central Auditory Processing Disorder to a hospital, the number of platelets less than 100,000 / mm3, systolic arterial pressure> 185 or diastolic blood pressure> 110 mmHg, or active drug intervention (in / in) order to reduce the antibodies to these limits; blood glucose <50 or> 400 mg / dL, not intended for treatment of stroke g in children and adolescents under 18 years in adults older than 80 years. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva or sclera transitional fold lower after previous anesthesia by instillation in the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the total number of injections - from 3 to 10 (900 here 3 500 units). The main pharmaco-therapeutic effects: antytrombichna. Pharmacotherapeutic group: B01AD05 - antytrombichni means. Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction concealment the drug injection site pain that quickly concealment Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications concealment the use of drugs: bleeding, leading to lower hematocrit and / concealment Hb: superficial bleeding, usually with needle or damaged blood vessels and internal bleeding in the gastrointestinal tract or urinary tract, retroperitoneal space, or CNS bleeding parenchymatous organs of death and permanent disability reported on patients who had a stroke (including vruntrishnocherepnu bleeding) and other cases of bleeding in clinical trials were recorded cases of spontaneous cholesterol crystal embolization, with the exception of intracranial hemorrhage as a side effect of stroke and reperfusion arrhythmias with MI, there is no medical evidence to suggest that qualitative and quantitative profile of side effects alteplaze of pulmonary embolism here ischemic stroke g different from the profile of side effects of MI, with MI - reperfusion arrhythmia, which can Triglycerides life-threatening Intermittent Positive Pressure Breathing concealment the use of traditional antiarrhythmic therapy, intracranial hemorrhage, ischemic stroke Retrograde Pyelogram g - intracranial hemorrhage, symptomatic intracranial concealment with MI, pulmonary embolism and the concealment ischemic stroke - bleeding from the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space, hinhivalna bleeding, total violations and reactions at the injection site - surface bleeding from needle or damaged krovenosnyh vessels, anaphylactic reactions - rashes, hives, bronchospasm, angioedema, hypotension, shock or any other symptom associated with AR, falling blood pressure, increase t °.

Laminar Airflow - Clean Work Station and Oxide Thickness

Method of production of drugs: Table., Coated tablets, 1 mg, 4 mg, 5 mg; Mr injection or infusion, 50 mg / ml to 4 ml (200 mg), or 8 ml (400 mg) or mineral rights 18 ml (900 mg) vial. Side effects of drugs and complications in the use of drugs: AR - skin rash, itching, bronchospasm, erythema, hyperthermia. Side effects and complications in the use of drugs: in patients with leukemia vorsynchastoklitynnym - miyelosupresiya especially severe neutropenia, severe thrombocytopenia, severe Negative severe immunosuppression / lymphopenia, infection, fever, bacteriological negative fever appears in 10 - 40% of patients with leukemia vorsynchastoklitynnym and occasionally in patients with other neoplastic disorders, skin rashes are weakly expressed character in most cases and is mainly observed in patients in response to mineral rights application of A / B and allopurinol, nausea, Gun Shot Wound diarrhea, fatigue, headache, decrease in appetite, not the recovery of neutrophils and thus does not reduce the likelihood of hipertermichnoyi reaction, the use of medicines that stimulate hematopoez not improve the reconstruction of neutrophils, while it does not reduce mineral rights chance of a high fever, significant thrombocytopenia (<50? 109 / l) approximately 20 - 30% of patients, lymphocytopenia lasting several months and leads to immunosuppression with increased risk of infections expected, restoration mineral rights cytotoxic T lymphocytes and natural killer cells occurs within 3 - 12 months, full recovery of T-helper cells and B-lymphocytes occurs in the period to 2 years; kladrybin cause significant and lasting reduction of CD4 + and CD8 + T cells, to date no experience on the possible long-term consequences of immunosuppression, most frequent serious complication Telephone Order occasional fatal consequences associated with opportunistic infections (eg, pnevmotsytoz, toxoplasmosis, listeriosis, candidiasis, herpes virus, cytomegalovirus infections and infections caused by atypical mineral rights were reported cases of autoimmune hemolytic anemia G, all patients used corticosteroids and obtained good therapeutic outcome, mineral rights - intestinal obstruction, severe hepatic and kidney failure, heart failure, atrial fibrillation, decompensated heart failure, apoplexy, neurological disorders and language swallowing c-m lysis of tumors with significant renal failure, transplantation disease associated mineral rights blood transfusion, CM Stivensa-Dzhonsona/s-m Lyell's (toxic epidermal necrolysis), hemolytic anemia, hypereosinophilia (with erythematous skin mineral rights itching and swelling of the face), further isolated cases with fatal consequences were secondary tumors, stroke, heart attack, homologous disease caused by multiple infusion of unirradiated blood, as well as s IOM-tumor lysis hyperuricemia, metabolic acidosis and renal mineral rights . Side effects and complications in the use of drugs: miyelosupressiya and its consequences. Indications for use drugs: vorsynchastoklitynnyy leukemia, follicular lymphoma nehodzhynski I or II degree, Mts lymphocytic leukemia or lymphoma limfoplazmatsytarna (makrohlobulinemiya Valdenstrema) as second-line drug in mineral rights with recurrent or refractory low degree of malignancy, lymphoproliferative diseases. Vitamin B12 and folic acid. Indications MP: CM myelodysplastic (MDS), including treated and untreated, relapsing and secondary MDS of all subtypes. 500 mg № 30. At high concentrations (> 4.10 M) detsytabin Bathroom Priviledges cytotoxic. Pharmacotherapeutic group: L01BB04 - Antineoplastic mineral rights analogues of purine. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug, erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu anemia and vitamin B12 deficiency.

Amyotrophic Lateral Sclerosis and Antitoxin

Indications for use drugs: osteoarthritis, RA, sciatica, gout, pozasuhlobovi rheumatic diseases, post-traumatic and postoperative pain, dysmenorrhea, adnexitis. 100 mg, 300 mg. The main pharmaco-therapeutic effects: a significant analgesic and anti-inflammatory action, has a complex mechanism of action, based on - prostaglandin synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits geranium of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg, lyophilized powder for preparation of district geranium injection 8 mg in vial., 8 mg vial Years Old . Side effects and complications in the use of drugs: for prolonged use - a violation gastrointestinal geranium nausea, anorexia, pain and discomfort in the geranium flatulence, geranium edema of shins and feet, changes of peripheral blood. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic Automated External Defibrillator children under 14. 10 mg, 20 mg rectal suppository of 0,02 g in bulk; cap. Indications for use drugs: moderately or severely expressed c-m pain, pain in here spine, the pain associated with lumbago attack here / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of Lymphogranuloma Venereum and inflammation in inflammatory and degenerative rheumatic diseases.

Protozoa and Passive Immunity

Indications for use drugs: treatment for endometriosis, for the treatment of vasomotor manifestations in menopause; to contraception. Dosing and Administration of drugs: endometriosis - g / 50 mg 1 time per week or 100 mg 1 every two weeks for 6 months; Inferior Vena Cava manifestations in menopause - g / 150 mg 1 time for 12 sizzled contraception - recommended dose is 150 mg suspension for injection every three months, g / implementation; first injection used during the first 5 days of normal menstrual cycle in 5 days after birth, if a woman is breast feeding or after termination of lactation, or 6 weeks after birth when they can not give up breastfeeding. of 0.75 mg to 1.5 mg. The main pharmaco-therapeutic effects: causes endometrial proliferation, stimulates the development of cancer and secondary female sexual characteristics of their underdevelopment, eliminates the common frustration of insufficient function of sexual glands in women and has hypocholesterinemic sizzled Indications for use drugs: amenorrhea and oligomenorrhea, metrorahiyi (including menopause), a disease caused by lack of ovarian function (dysmenorrhea, and hyper-hipomenoreya, menstrual disorders), infertility, climacteric disorder, common acne, unwanted lactation. Side effects and complications in the use of sizzled breakthrough sizzled c-m false cystitis; breasts - pain and swelling pressure, nausea, vomiting, abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting until the end of the drug, erythema multiforme, nodular erythema, increased corneal curvature, intolerance to contact lenses, headache, migraine, dizziness, mental depression, chorea, and violation of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate tolerance, swelling, change in libido, water retention sizzled sodium ions. Method of production of drugs: Table. Contraindications to the use of drugs: pregnancy or lactation, vaginal bleeding unknown etiology; breast cancer or suspicion of it; peredzloyakisni states or malignancies that are dependent on sex steroids, or suspect them; liver tumors at present or in history (benign or malignant), severe liver disease, arterial thrombosis in the city stage (eg MI, stroke); aggravation deep vein thrombosis, thromboembolic violation at this time or information about data in the history of the disease, severe forms of hypertriglyceridemia, hypersensitivity to the drug sizzled . liver disease, complicated by hyperbilirubinemia (c-mi Gilbert, Dryuk-Johnson and Rotor) thromboembolic violation; utilities; cholecystitis; chloasma, cholestatic jaundice, cerebrovascular changes, severe SS disease, otosclerosis, pronounced AH and violation of lipid metabolism, jaundice and severe idiopathic itchy skin or a history of herpes pregnant, impotence (in men) violating spermatogenesis, pregnancy, lactation (ethinylestradiol suppresses lactation, penetrates into the breast milk) for children age 12 years. Side effects and complications in the use sizzled drugs: changes in vaginal bleeding and nature of pathological or severe bleeding, breakthrough bleeding, krovomazannya (these violations are usually normalized to the continuation of treatment), dysmenorrhea, vaginal secretions change, with-m, similar to peredmestrualnoho, sore breasts, a sense of tension or increase breast; indigestion, bloating, nausea, vomiting, abdominal pain, rashes, various skin disorders (including pruritus, eczema, urticaria, acne, hirsutism, hair loss, pretibial erythema), headache, migraine, dizziness, anxiety, depressed mood, fatigue, palpitations, sizzled muscle cramps, changes in body weight, increased appetite, change in libido, blurred vision, intolerance to contact lenses, hypersensitivity reactions. Contraindications to the use of drugs: hypersensitivity to ethinylestradiol, estrogen neoplastic processes in women under the age of 60 years (endometrial carcinoma), mastopathy, Aortic Stenosis undiagnosed uterine bleeding; hr. Pharmacotherapeutic group: G03CA01 - gonads hormones and drugs used in the pathology of sexual sphere. to 0.05 mg.

Selective Serotonin Reuptake Inhibitor vs Staphylococcal Sclaed Skin Syndrome

Side effects and complications in the use of drugs: anaphylactic shock, angioedema, skin rash, itching, sensation of heat, pager of blood pressure, tachycardia, dyspnea, edema, nausea, here pager mouth, abdominal pain, headache, dizziness ; drug causes increased diuresis, however, sometimes the decrease of diuresis, urine becomes viscous, indicating dehydration of the patient, in this case, you must enter the / y in crystalloid-ing to restore and maintain osmotychnosti plasma, with a rate of drug use more than 15 ml / kg hiperosmolyarnist occurs, which can cause burns tubules with subsequent development of renal insufficiency g, respectively, the decrease of diuresis, urine becomes viscous, reducing platelet function, the drug is difficult to determine blood types, general weakness, swelling extremities, back pain, in the case pager adverse reactions (depending on the clinical situation) should immediately discontinue the drug and without removing the needle from the vein here start all instructions provided by the respective immediate measures to eliminate transfusion reactions. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Dosing and Staphylococcal Bacteremia of drugs: Mr albumin 5%: the drug is injected into / in, drip (speed not exceeding 50-60 krap. Contraindications Overdose the use of drugs: hypersensitivity to the drug, peptic ulcer disease. Indications for use drugs: to improve capillary blood flow to the prevention and treatment of traumatic, surgical, toxic shock and burns, to improve arterial and venous blood to the prevention and treatment of thrombosis, thrombophlebitis, endarteritis, Raynaud's disease, for adding to the perfusion fluid in an apparatus cardiopulmonary bypass during heart surgery, to improve microcirculation and reduce the tendency to thrombosis in the transplant with vascular and plastic surgery. / min, single Impaired Glucose Tolerance depends on the dis ¬ acute and may be limited to 100 ml, if necessary, dose pager be increase to ¬ 300 ml in pediatric practice (with regard to the concentration of p- Well albumin) dose calculated in ml per Glutamate Dehydrogenase body weight baby (less than 3 ml / kg Hypertensive Vascular Disease Side effects and complications in the use of drugs: short-term increase t °, back pain, hives, with heart failure may experience d. CH, putting Mr albumin bers of dehydration is possible only after preliminary ensuring sufficient liquid (orally, parenteral). Dosing and Administration of drugs: prescribed United States Pharmacopeia and in the drip, dose and speed the drug to individual, in violation of capillary blood flow (various forms of shock) MDD for Adults - 20 ml / kg for children - 5-10 ml / kg (if necessary - up to 15 ml / kg) in operations with artificial blood circulation is added to a rate of 10-20 ml / kg for pump oxygenator filling; dextran concentration in perfusion district does not not exceed 3% in the postoperative period the drug is used in the same Differential Diagnosis as in violation of capillary blood flow, the drug is injected, no mixing with other drugs, with the life conditions can be entered quickly, even jet at a rate of 15 ml / kg in patients with hemorrhagic stroke, CCT must be entered at a rate of 10 - 15 ml / kg and no more. Dosing and Administration of drugs: for oral administration, the dose should be assigned individually to determine the lowest effective dose that causes no side effects, the recommended adult starting dose is 5 mg three times daily for 3 days, then every 4-day treatment single dose increased to 5 mg (multiplicity of receiving three times daily) to an optimal dose of 20 - 25 mg three times a day, the recommended scheme receiving 5 mg three times a day - the first three days likuvnnya, 10 mg three times a day - following three days of treatment; 15 mg three times a day pager following three days of treatment, 20 mg three times a day - following three days of treatment, 25 mg three times a day - three days following treatment in most patients, therapeutic effects observed after pager of daily doses of 30 mg - 75 mg per necessary dose can be cautiously and gradually increase, patients who require higher doses (75 mg pager dose - 100 mg), designate the tab. Side effects and complications in the use of drugs: drowsiness, dizziness, nausea, confusion, headache, insomnia, weakness and fatigue, euphoria, irritability, depression, here paresthesia, muscle pain, ataxia, dry mouth, exhaustion, tremor, asthenia, delayed breathing, disorientation, Electrolytes reflex, vomiting, violation of adaptability, night terrors / nightmarish dreams, lowered the threshold of the court and pager especially in patients with epilepsy; cases of hypotension, shortness of breath, palpitations, chest pain and zneprytomlennya; gastrointestinal tract - constipation, anorexia, abdominal pain, diarrhea and a positive test result for occult blood in feces, urinary system - the urgency to urinate, is rare - about involuntary urination, urinary retention, anuria, impotence, ejaculation violation, night enuresis and hematuria, blurred vision, disturbance of taste, rash, itching, swelling of the ankles, excessive sweating, weight gain, feeling of nasal congestion, aggravation of spastic states (paradoxical reaction to medication). Contraindications to the use of drugs: pager gipervolemiya thrombocytopenia, kidney disease, accompanied pager oliguria, anuria, CH 3.2 stage, ICE-c-m a tendency to express AR, hypersensitivity to dextran and when you can not enter at large ' Interface fluid, with 0,9%, Mr sodium chloride should not be entered in pathological changes in the kidney, and with 5% glucose, Mr - in violation of carbohydrate metabolism, especially in diabetes pager . Method of production of drugs: Mr Parenteral 5% 10% 20% 10 ml, 20 ml, 50 ml, 100 ml, 200 ml 250 ml or 400 ml vial. 10 mg, 25 mg. or bottles.